Omeros (OMER) Cash from Investing Activities (2010 - 2026)

Omeros' (OMER) quarterly Cash from Investing Activities came in at $28.7 million in Q1 2026, down 25.45% year-on-year from $38.5 million in Q1 2025, and down 74.24% quarter-over-quarter from $111.5 million in Q4 2025.

Omeros (OMER) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Omeros has disclosed Cash from Investing Activities across 17 years of filings, most recently posting $28.7 million for Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $28.7 million, down 25.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $154.7 million (down 15.31% YoY), and the FY2025 annual result was $164.5 million, up 100.11% from the prior year.
  • Cash from Investing Activities came in at $28.7 million for Q1 2026 at Omeros, down from $111.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $116.2 million in Q4 2023 to a low of -$181.3 million in Q1 2023.
  • The 5-year median for Cash from Investing Activities is $33.0 million (2022), against an average of $10.3 million.
  • Across the five-year window, Cash from Investing Activities sank 332.87% in 2022 and surged 219.12% in 2025, its largest moves.
  • Omeros' Cash from Investing Activities stood at -$108.5 million in 2022, then soared by 207.15% to $116.2 million in 2023, then plunged by 69.93% to $35.0 million in 2024, then soared by 219.12% to $111.5 million in 2025, then sank by 74.24% to $28.7 million in 2026.
  • The last three Cash from Investing Activities figures came in at $28.7 million (Q1 2026), $111.5 million (Q4 2025), and -$6.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn 28.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.73 Mn
Mar 31, 2026 28.73 Mn
Dec 31, 2025 111.55 Mn
Dec 31, 2025 111.55 Mn
Sep 30, 2025 -6.86 Mn
Sep 30, 2025 -6.86 Mn
Jun 30, 2025 21.30 Mn
Jun 30, 2025 21.30 Mn
Mar 31, 2025 38.54 Mn
Mar 31, 2025 38.54 Mn
Dec 31, 2024 34.95 Mn
Dec 31, 2024 34.95 Mn
Sep 30, 2024 36.04 Mn
Sep 30, 2024 36.04 Mn
Jun 30, 2024 73.15 Mn
Jun 30, 2024 73.15 Mn
Mar 31, 2024 -61.93 Mn
Mar 31, 2024 -61.93 Mn
Dec 31, 2023 116.24 Mn
Dec 31, 2023 116.24 Mn